CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway

Open access
Miao, Youhan, Wang, Meihua, Cai, Xiaojuan, Zhu, Qiqi, Mao, Liping · 2022 · Bioengineered

Abstract

Sepsis-associated encephalopathy (SAE) is key manifestation of sepsis which is responsible for increased morbidity and mortality. Leucine rich alpha-2-glycoprotein 1 (Lrg1) is a secreted protein implicated in a variety of diseases. We aimed to explore the effects and potential mechanism of Lrg1 on sepsis-mediated brain injury. A sepsis-induced brain damage mice model was established. Then, ELISA was utilized to detect the levels of inflammatory factors in brain tissues. Behavioral performance, spatial learning and memory of mice were evaluated by open field test and Morris water maze test. The number of neurons was tested by H&E staining. Lrg1 expression was evaluated by RT-qPCR and western blot. In vitro, mouse hippocampal neuronal cell line (HT22) was stimulated by lipopolysaccharide (LPS). After Lrg1 silencing, cell viability was determined using CCK-8 and cell apoptosis was assessed by TUNEL. The levels of inflammatory factors were detected by ELISA. Moreover, western blot was applied to analyze the expression of proteins in transforming growth factor beta1 (TGFβ1)/SMAD signaling. Results revealed that mice in the model group showed obvious behavioral changes. Lrg1 was highly expressed in the brain tissues of model mice. Besides, Lrg1 knockdown suppressed the inflammation and apoptosis of LPS-induced HT22 cells. Moreover, Lrg1 silencing caused the inactivation of TGFβ1/SMAD signaling. Rescue assays confirmed that TGFβ1 overexpression reversed the impacts of Lrg1 deletion on the inflammation and apoptosis in LPS-induced HT22 cells. Collectively, Lrg1 silencing alleviates brain injury in SAE via inhibiting TGFβ1/SMAD signaling, implying that Lrg1 might serve as a promising target for SAE treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21655979.2022.2048775

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY · PubMed Central
Figure 1. Sepsis model mice exhibit brain behavioral changes. The levels of inflammatory factors (a) TNF-α, (b) IL-6, (c) IL-1β and (d) IL-18 were assessed by ELISA analysis. (E-F) OFT was to detect the spontaneous viability of sepsis mice. (G-J) MWM was to explore the cognitive function of sepsis mice. (k) H&E staining was to evaluate the number of neurons of hippocampal tissues in sepsis mice. (Magnification, x200). (l) RT-qPCR and (m) western blot were respectively to analyze Lrg1 mRNA and protein expression. **P<0.01, ***P<0.001.
Figure 1. Sepsis model mice exhibit brain behavioral changes. The levels of inflammatory factors (a) TNF-α, (b) IL-6, (c) IL-1β and (d) IL-18 were assessed by ELISA analysis. (E-F) OFT was to detect the spontaneous viability of sepsis mice. (G-J) MWM was to explore the cognitive function of sepsis mice. (k) H&E staining was to evaluate the number of neurons of hippocampal tissues in sepsis mice. (Magnification, x200). (l) RT-qPCR and (m) western blot were respectively to analyze Lrg1 mRNA and protein expression. **P<0.01, ***P<0.001.CC BY · PubMed Central
Figure 2. Silencing of Lrg1 ameliorates the inflammation of LPS-induced mouse hippocampal neuronal cells. (a) Lrg1 expression was evaluated by RT-qPCR. (b) Cell viability was detected using a CCK-8 assay. ELISA analysis was to test the levels of inflammatory factors (c) TNF-α, (d) IL-6, (e) IL-1β and (f) IL-18. **P<0.01, ***P<0.001.
Figure 2. Silencing of Lrg1 ameliorates the inflammation of LPS-induced mouse hippocampal neuronal cells. (a) Lrg1 expression was evaluated by RT-qPCR. (b) Cell viability was detected using a CCK-8 assay. ELISA analysis was to test the levels of inflammatory factors (c) TNF-α, (d) IL-6, (e) IL-1β and (f) IL-18. **P<0.01, ***P<0.001.CC BY · PubMed Central
Figure 3. Silencing of Lrg1 ameliorates the apoptosis of LPS-induced mouse hippocampal neuronal cells. (a) TUNEL assay was to detect cell apoptosis. (Magnification, x200). (b) Western blot was to analyze the protein levels of apoptosis-related factors. ***P<0.001.
Figure 3. Silencing of Lrg1 ameliorates the apoptosis of LPS-induced mouse hippocampal neuronal cells. (a) TUNEL assay was to detect cell apoptosis. (Magnification, x200). (b) Western blot was to analyze the protein levels of apoptosis-related factors. ***P<0.001.CC BY · PubMed Central
Figure 4. Inhibition of Lrg1 inactivates the TGFβ1/SMAD signaling pathway in LPS-stimulated HT22 cells. Western blot was to analyze the protein levels of related factors in TGFβ1/SMAD signaling pathway. ***P<0.001.
Figure 4. Inhibition of Lrg1 inactivates the TGFβ1/SMAD signaling pathway in LPS-stimulated HT22 cells. Western blot was to analyze the protein levels of related factors in TGFβ1/SMAD signaling pathway. ***P<0.001.CC BY · PubMed Central
Figure 5. Lrg1 silencing attenuates LPS-induced inflammation of HT22 cells through inhibition of TGFβ1/SMAD signaling pathway. (a) Western blot was to analyze the overexpression efficiency of Lrg1. (b) CCK-8 assay was to evaluate cell viability. ELISA analysis was to examine the levels of inflammatory factors (c) TNF-α, (d) IL-6, (e) IL-1β and (f) IL-18. **P<0.01, ***P<0.001.
Figure 5. Lrg1 silencing attenuates LPS-induced inflammation of HT22 cells through inhibition of TGFβ1/SMAD signaling pathway. (a) Western blot was to analyze the overexpression efficiency of Lrg1. (b) CCK-8 assay was to evaluate cell viability. ELISA analysis was to examine the levels of inflammatory factors (c) TNF-α, (d) IL-6, (e) IL-1β and (f) IL-18. **P<0.01, ***P<0.001.CC BY · PubMed Central
Figure 6. Lrg1 silencing attenuates LPS-induced apoptosis of HT22 cells through inhibition of TGFβ1/SMAD signaling pathway. (A) TUNEL assay was to detect cell apoptosis. (Magnification, x200). (B) Western blot was to analyze the protein levels of apoptosis-related factors. **P<0.01, ***P<0.001.
Figure 6. Lrg1 silencing attenuates LPS-induced apoptosis of HT22 cells through inhibition of TGFβ1/SMAD signaling pathway. (A) TUNEL assay was to detect cell apoptosis. (Magnification, x200). (B) Western blot was to analyze the protein levels of apoptosis-related factors. **P<0.01, ***P<0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 50 references

Research works printed but not linked: 1

  1. Yu J, Chen J, Yang H, et al. Overexpression of miR200a3p promoted inflammation in sepsisinduced brain injury through ROSinduced NLRP3. Int J Mol Med. 2019;44(5):1811–1823.

Cited by

See all 23

Metadata

Authors
Miao, Y., Wang, M., Cai, X., Zhu, Q., & Mao, L.
Affiliations
The Third People’s Hospital of Nantong
Corresponding author
Mao, Liping
Venue
Bioengineered
Published
2022-03
Volume
13
Issue
3
Pages
7316-7327
ISSN
  • 2165-5979 (ISSN-L)
  • 2165-5987
OpenAlex
W4220901556
Cited by
22
References
50
Citations by year
2026: 3 · 2025: 7 · 2024: 6 · 2023: 5 · 2022: 1
FWCI
3.43
Type
journal article
Language
en
Open access
Locations
  • Bioengineered (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
research
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
LRG1, sepsis-associated encephalopathy, lipopolysaccharide-induced neuroinflammation, neuronal apoptosis, hippocampal neurons, neuroprotection, cognitive impairment
MeSH terms
Animals, Brain Injuries, Glycoproteins, Inflammation, Leucine, Lipopolysaccharides, Signal Transduction, Apoptosis, Sepsis, Mice, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway. https://app.cochat.ai/papers/10.1080/21655979.2022.2048775
The paper
Miao, Y., Wang, M., Cai, X., Zhu, Q., & Mao, L. (2022). Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway. Bioengineered. https://doi.org/10.1080/21655979.2022.2048775

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.